title: Recent evidence regarding triclosan and cancer risk.
abstract: Triclosan is a broad-spectrum antibacterial commonly used in cosmetics, dentifrices, and other consumer products. The compound's widespread use in consumer products and its detection in breast milk, urine, and serum have raised concerns regarding its potential association with various human health outcomes. Recent evidence suggests that triclosan may play a role in cancer development, perhaps through its estrogenicity or ability to inhibit fatty acid synthesis. Our aims here are to review studies of human exposure levels, to evaluate the results of studies examining the effects of triclosan on cancer development, and to suggest possible directions for future research.
authors.affiliation: Department of Public Health, University of Tennessee, Knoxville, TN 37996, USA. mdinwidd@utk.edu.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Dinwiddie
authors.affiliation: Department of Public Health, University of Tennessee, Knoxville, TN 37996, USA. pdterry@utk.edu.
authors.forename: Paul D
authors.initials: PD
authors.lastname: Terry
authors.affiliation: Department of Public Health, University of Tennessee, Knoxville, TN 37996, USA. jchen38@utk.edu.
authors.forename: Jiangang
authors.initials: J
authors.lastname: Chen
mesh_terms: D000891:Anti-Infective Agents, Local / Q000633:toxicity*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D012306:Risk; D014260:Triclosan / Q000633:toxicity*
chemical_list: D000891:Anti-Infective Agents, Local; D014260:Triclosan